OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

NCT07136012 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

11000

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: Olpasiran
DRUG: Placebo

Sponsor

Amgen